Clinical Trial Update: Angiotensin II Blockade for Chronic Allograft Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 trial update on angiotensin II blockade for chronic allograft nephropathy; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Disease
• Proteinuria

Snippet

Sponsor: University of Minnesota | Conditions: Kidney Disease, Proteinuria | Phase 4 | Status: COMPLETED | Results posted: 2017-09-18